Filing Details
- Accession Number:
- 0001535610-18-000068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-14 15:42:41
- Reporting Period:
- 2018-03-12
- Accepted Time:
- 2018-03-14 15:42:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1362959 | Rosetta Genomics Ltd. | ROSG | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1535610 | Sabby Management, Llc | 10 Mountainview Road Suite 205 Upper Saddle River NJ 07458 | No | No | Yes | No | |
1561018 | Sabby Healthcare Master Fund, Ltd. | C/O Sabby Management, Llc 10 Mountainview Road, Suite 205 Upper Saddle River NJ 07458 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 20,373 | $0.42 | 595,094 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 454 | $0.40 | 595,548 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 2,604 | $0.42 | 598,152 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 11,521 | $0.41 | 609,673 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 21,800 | $0.41 | 631,473 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 24,600 | $0.42 | 656,073 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 24,162 | $0.42 | 680,235 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 10,605 | $0.42 | 690,840 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 12,390 | $0.41 | 703,230 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-12 | 10,000 | $0.42 | 713,230 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-13 | 30,990 | $0.42 | 744,220 | No | 4 | P | Indirect | See Footnotes |
Adr Shares (Each One Equal To 2 Ordinary Shares) | Acquisiton | 2018-03-13 | 6,329 | $0.42 | 750,549 | No | 4 | P | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
Footnotes
- This Form 4 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor.
- The amounts reported herein reflect the entire amount of Issuer's ADR shares held by SHMF and SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.